Literature DB >> 25085358

Sequential treatment for allogeneic hematopoietic stem cell transplantation in Fanconi anemia with acute myeloid leukemia.

Alexis Talbot1, Régis Peffault de Latour1, Emmanuel Raffoux2, Nimrod Buchbinder3, Stéphane Vigouroux4, Noel Milpied4, Thierry Leblanc5, Jean Soulier6, Mauricette Michallet7, Gérard Socié8.   

Abstract

Entities:  

Keywords:  AML; Fanconi anemia; sequential chemotherapy; transplantation

Mesh：

Year:  2014        PMID： 25085358      PMCID： PMC4181270          DOI： 10.3324/haematol.2013.098954

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  7 in total

1.  Cancer in Fanconi anemia.

Authors:  Blanche P Alter; Mark H Greene; Isela Velazquez; Philip S Rosenberg
Journal:  Blood       Date:  2003-03-01       Impact factor: 22.113

2.  Sequential regimen of chemotherapy, reduced-intensity conditioning for allogeneic stem-cell transplantation, and prophylactic donor lymphocyte transfusion in high-risk acute myeloid leukemia and myelodysplastic syndrome.

Authors:  Christoph Schmid; Michael Schleuning; Georg Ledderose; Johanna Tischer; Hans-Jochem Kolb
Journal:  J Clin Oncol       Date:  2005-08-20       Impact factor: 44.544

3.  National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report.

Authors:  Alexandra H Filipovich; Daniel Weisdorf; Steven Pavletic; Gerard Socie; John R Wingard; Stephanie J Lee; Paul Martin; Jason Chien; Donna Przepiorka; Daniel Couriel; Edward W Cowen; Patricia Dinndorf; Ann Farrell; Robert Hartzman; Jean Henslee-Downey; David Jacobsohn; George McDonald; Barbara Mittleman; J Douglas Rizzo; Michael Robinson; Mark Schubert; Kirk Schultz; Howard Shulman; Maria Turner; Georgia Vogelsang; Mary E D Flowers
Journal:  Biol Blood Marrow Transplant       Date:  2005-12       Impact factor: 5.742

Review 4.  Haematopoeitic cell transplantation for Fanconi anaemia - when and how?

Authors:  Margaret L MacMillan; John E Wagner
Journal:  Br J Haematol       Date:  2010-02-05       Impact factor: 6.998

5.  Risk of head and neck squamous cell cancer and death in patients with Fanconi anemia who did and did not receive transplants.

Authors:  Philip S Rosenberg; Gerard Socié; Blanche P Alter; Eliane Gluckman
Journal:  Blood       Date:  2004-08-26       Impact factor: 22.113

6.  Effective graft-versus-leukaemia effect after allogeneic stem cell transplantation using reduced-intensity preparative regimens in Fanconi anaemia patients with myelodysplastic syndrome or acute myeloid leukaemia.

Authors:  Philippe Guardiola; Peter Kurre; Amalia Vlad; Jean-Michel Cayuela; Hélène Espérou; Agnès Devergie; Patricia Ribaud; Gérard Socié; Patrice Richard; Richard Traineau; Rainer Storb; Eliane Gluckman
Journal:  Br J Haematol       Date:  2003-09       Impact factor: 6.998

7.  Cancer incidence in persons with Fanconi anemia.

Authors:  Philip S Rosenberg; Mark H Greene; Blanche P Alter
Journal:  Blood       Date:  2002-09-05       Impact factor: 22.113
  7 in total
  8 in total

1.  Genetic predisposition to myelodysplastic syndrome and acute myeloid leukemia in children and young adults.

Authors:  Daria V Babushok; Monica Bessler; Timothy S Olson
Journal:  Leuk Lymphoma       Date:  2015-12-23

2.  Minimal antileukaemic treatment followed by reduced-intensity conditioning in three consecutive children with Fanconi anaemia and AML.

Authors:  R Beier; B Maecker-Kolhoff; K-W Sykora; M Chao; C Kratz; M G Sauer
Journal:  Bone Marrow Transplant       Date:  2014-12-22       Impact factor: 5.483

Review 3.  Hematopoietic cell transplantation in Fanconi anemia: current evidence, challenges and recommendations.

Authors:  Christen L Ebens; Margaret L MacMillan; John E Wagner
Journal:  Expert Rev Hematol       Date:  2016-12-21       Impact factor: 2.929

Review 4.  Allogeneic hematopoietic stem cell transplantation for inherited bone marrow failure syndromes.

Authors:  Jean-Hugues Dalle; Régis Peffault de Latour
Journal:  Int J Hematol       Date:  2016-02-12       Impact factor: 2.490

Review 5.  Recommendations on hematopoietic stem cell transplantation for inherited bone marrow failure syndromes.

Authors:  R Peffault de Latour; C Peters; B Gibson; B Strahm; A Lankester; C D de Heredia; D Longoni; F Fioredda; F Locatelli; I Yaniv; J Wachowiak; J Donadieu; A Lawitschka; M Bierings; M Wlodarski; S Corbacioglu; S Bonanomi; S Samarasinghe; T Leblanc; C Dufour; J-H Dalle
Journal:  Bone Marrow Transplant       Date:  2015-06-08       Impact factor: 5.483

6.  HLA-haploidentical TCRαβ+/CD19+-depleted stem cell transplantation in children and young adults with Fanconi anemia.

Authors:  Luisa Strocchio; Daria Pagliara; Mattia Algeri; Giuseppina Li Pira; Francesca Rossi; Valentina Bertaina; Giovanna Leone; Rita Maria Pinto; Marco Andreani; Emanuele Agolini; Katia Girardi; Stefania Gaspari; Lavinia Grapulin; Francesca Del Bufalo; Antonio Novelli; Pietro Merli; Franco Locatelli
Journal:  Blood Adv       Date:  2021-03-09

7.  Clinical utility of gene panel-based testing for hereditary myelodysplastic syndrome/acute leukemia predisposition syndromes.

Authors:  L Guidugli; A K Johnson; G Alkorta-Aranburu; V Nelakuditi; K Arndt; J E Churpek; L A Godley; D Townsley; N S Young; C Fitzpatrick; D Del Gaudio; S Das; Z Li
Journal:  Leukemia       Date:  2017-01-20       Impact factor: 11.528

Review 8.  SAMD9 and SAMD9L in inherited predisposition to ataxia, pancytopenia, and myeloid malignancies.

Authors:  Josef Davidsson; Andreas Puschmann; Ulf Tedgård; David Bryder; Lars Nilsson; Jörg Cammenga
Journal:  Leukemia       Date:  2018-02-25       Impact factor: 11.528
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.